Live feed08:30:00·74dPRReleasevia Quantisnow+1Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&AByQuantisnow·Wall Street's wire, on your screen.ARWR· Arrowhead Pharmaceuticals Inc.JNJ· Johnson & JohnsonMGTX· MeiraGTx Holdings plcSUPN· Supernus Pharmaceuticals Inc.Health Care
